gene in clients relapsing immediately after procedure Together with the BCL2 antagonist venetoclax. 66 Resistance to those agents has become associated with these mutations in all around 70% of instances, although they are generally subclonal as well as their unique position causing resistance must be confirmed.Duvelisib was the 2nd PI3K inhibitor